Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J ECT. 2013 Mar;29(1):3–12. doi: 10.1097/YCT.0b013e31826ea8c4

Figure 1.

Figure 1

Kaplan-Meier estimates of the proportion of patients who remained well during the continuation pharmacotherapy trial for patients randomized to treatment with placebo or antidepressant medication (NT or VEN) during the ECT course.